LifeMD (LFMD) Enterprise Value (2012 - 2025)

LifeMD has reported Enterprise Value for 14 years, with the latest figure at -$37.1 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value fell 19.07% year-over-year to -$37.1 million; the trailing twelve-month figure through Dec 2025 stood at -$37.1 million (down 19.07% YoY), and the FY2025 full-year result was -$37.1 million, down 19.07% from the prior year.
• Enterprise Value for Q4 2025 stood at -$37.1 million, down from -$22.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$4.6 million in Q4 2022, with the low at -$42.6 million in Q4 2021.
• Historically, Enterprise Value has averaged -$23.5 million across 5 years, with a median of -$24.4 million in 2022.
• Annual changes were most pronounced in 2021 — Enterprise Value plunged 2359.45% — and 2022, when it soared 89.28%.
• LifeMD's Enterprise Value stood at -$42.6 million in 2021, then soared by 89.28% to -$4.6 million in 2022, then tumbled by 592.1% to -$31.6 million in 2023, then climbed by 1.29% to -$31.2 million in 2024, then retreated by 19.07% to -$37.1 million in 2025.
• The last three Enterprise Value figures came in at -$37.1 million (Q4 2025), -$22.1 million (Q3 2025), and -$34.3 million (Q2 2025), per Business Quant data.